In countries where hyperplastic goiter is not endemic, solitary thyroid nodules occur in 2-6% of the population but only 5-20% of these nodules are malignant (1, 2) . However, discrimination between malignant and benign lesions using scintigraphy, ultrasonography and other laboratory tests is not only costly but also unreliable.
Fine-needle aspiration biopsy (FNAB), well documen¬ ted by Scandinavian authors (3) , is widely accepted as the most effective procedure for detecting malignancy in thyroid nodules (4) (5) (6) (7) and is often recommended as the initial diagnostic test for investigating these lesions. Nevertheless, many groups, especially in Europe, have been reluctant to use FNAB for several reasons: the quality of smears depends mainly on the experience of the operator and the accuracy of interpretation is determined by the experience of the cytologist (8, 9) ; the false negative rate in recent reports ranges from 2 to 18% (5, (10) (11) (12) (13) (14) (15) . Finally, with FNAB it is sometimes difficult to discriminate between the various types of follicular tumors (16) (17) (18) (24) . A preliminary report shows that this method could be of interest on cytological samples (25) (27) . It (Fig. 4) (7, 12, 14) . Taking into account that nearly all patients with such diagnosis undergo surgery and that the goal of cytology is to select thyroid nodules for surgery, it seems more correct to put these results together with malignant responses in the evaluation of accuracy. The specificity of cytology for the diagnosis of malignancy fluctuates then from 45% to 70.6% (7, 13 
